临床表现 临床表现
Yun Cai1, Rebecca West1, Sharon Sanz Simon1
1Herbert and Jacqueline Krieger Klein Alzheimer's Research Center at Rutgers Brain Health Institute, New Brunswick, NJ, USA.
Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 25, 2025
概括
招募南亚和中东/北非 (MENA) 个体用于阿尔茨海默病和相关痴呆症 (ADRD) 研究提出了挑战. 萨梅纳队列研究旨在通过制定文化定制的战略来解决这一差距,以便在ADRD研究中获得更好的代表性.
科学领域:
- 神经科学是一个神经科学.
- 公共卫生 公共卫生
- 遗传学 遗传学 是一个
背景情况:
- 南亚和中东/北非 (MENA) 人口在阿尔茨海默病和相关痴呆症 (ADRD) 研究中的代表性显著不足.
- 有证据表明,在不同种族和种族群体中,ADRD风险因素,保护因素和生物标志物概况存在差异.
- 萨梅纳队伍旨在通过收集这些代表性不足的社区中ADRD患者的后代的纵向数据来弥补这一差距.
研究的目的:
- 招募来自南亚和MENA社区的参与者参加ADRD研究.
- 收集关于ADRD风险和保护因素的全面,纵向数据.
- 为这些人群制定量身定制的预防和治疗策略提供信息.
主要方法:
- 多方位的招聘策略包括社区外展 (广播,电视,健康营),社交媒体,与社区领导人和组织的合作伙伴关系,以及利用大学网络.
- 与招聘公司合作进行数字广告和医疗记录挖掘.
- 对参与者进行查和招募到SAMENA队列中.
主要成果:
- 在六个月的时间里,大约有300人联系了这项研究;90%的人因种族/种族而没有资格参加.
- 招募了12名参与者 (8名南亚人,4名MENA人),年龄在45-64岁之间,其中6名女性,8名拥有高级学位.
- 招募的参与者表现出正常的基线认知功能 (MoCA平均值=28.4,SD=1.5).
结论:
- 最初的招聘在达到目标南亚和MENA人口方面面临重大挑战.
- 需要进一步的研究来确定和完善文化定制的招聘策略,通过吸引各种利益相关者.
- 扩大招聘标准,包括其他痴呆风险因素 (例如肥胖,糖尿病,高血压) 的个人可能是有益的.
相关概念视频
Chronic Kidney Disease II: Clinical Manifestations
520
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
520
Coronary Artery Disease III: Clinical Manifestations
299
Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
299
Endocarditis II: Clinical Features of Infective Endocarditis
364
Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
364
Heart Failure III: Clinical Manifestations
436
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
436
Gastroesophageal Reflux Disease II: Clinical Features and Management
652
Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
652
Hypertension III: Clinical Manifestations and Diagnostic Studies
437
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
437


